The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1379
ISSUE1379
December 12, 2011
Rivaroxaban (Xarelto) for Acute Coronary Syndrome
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Rivaroxaban (Xarelto) for Acute Coronary Syndrome
December 12, 2011 (Issue: 1379)
The standard antithrombotic therapy for treatment of
patients with acute coronary syndrome (ACS) is dual
antiplatelet therapy with aspirin and clopidogrel (Plavix)
or another thienopyridine, plus a parenteral anticoagulant
while the patient is...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.